Table 1.
Setting | Targeted Pathway | Model | Targeted Gene | Targeted Tissue/Cell | Kidney Phenotypical Changes | Reference |
---|---|---|---|---|---|---|
AKI | Autophagy | Sepsis: LPS | Atg7 | Proximal tubules | Exacerbated proximal tubular cell injury and worsening kidney function | 35 |
Atg7 | Proximal tubules | Tubular cell apoptosis and impaired kidney function | 36 | |||
Atg5 | Podocytes | Increased transient albuminuria | 13 | |||
Mitophagy | Sepsis: CLP, LPS | Pink1 or Prkn | Global | Increased mitochondrial fragmentation, tubular damage, apoptosis, serum creatinine, and BUN | 37 | |
Autophagy | Cisplatin | Atg5 | Proximal tubules | Increased DNA damage, apoptosis, oxidative stress, number of protein aggregates, tissue damage, and impaired kidney function | 38 | |
Atg7 | Proximal tubules | Exacerbated cell death, tissue damage, and impaired kidney function | 39 | |||
Mitophagy | Cisplatin | Pink1 or Prkn | Global | Increased tubular injury, apoptosis, serum creatinine, and BUN | 40 | |
Pink1 | Global | Reduced DRP1, tubular apoptosis, and kidney injury | 41 | |||
Autophagy | IRI | Atg5 | Tubules | Increased tubular injury, apoptosis, and serum creatinine | 16 | |
Atg5 | Proximal tubules | Increased number of abnormal mitochondria, tubular cell death, kidney damage, serum creatinine, and BUN | 42 | |||
Atg7 | Proximal tubules | Increased serum creatinine and BUN | 39 | |||
Atg7 | Tubules | Reduced FGF2 expression and fibrotic responses | 43 | |||
Atg5 | Tubules | Exacerbated kidney injury and tubulointerstitial fibrosis | 44 | |||
Atg5 | Distal tubules | Increased fibrotic responses | 44 | |||
Becn1 | Tubules | Exacerbated tissue damage, inflammation, tubulointerstitial fibrosis, and impaired kidney function | 44 | |||
Becn1 | Distal tubules | Worsening kidney function | 44 | |||
Mitophagy | IRI | Pink1 or Prkn | Global | Exacerbated oxidative stress, inflammation, apoptosis, and mitochondrial damage in proximal tubules | 45 | |
Mfn2 | Proximal tubules | Increased cell survival and improved kidney function | 46 | |||
CKD | Autophagy | Kidney fibrosis/UUO | Map1lc3a | Global | Increased TGF-β1 expression, collagen accumulation, and kidney fibrosis | 47 |
Atg5 | Proximal tubules | Cell cycle arrested at the G2/M phase and increased tubulointerstitial fibrosis | 48 | |||
Atg5 | Proximal tubules | Increased inflammation, NF-κB activation, infiltration of macrophages and T cells in the kidney | 49 | |||
Atg7 | Distal tubules | Increased accumulation of abnormal mitochondria, apoptotic markers, NLRP3 inflammasome formation, and kidney fibrosis | 50 | |||
Atg7 | Proximal tubules | Reduced tubular atrophy, nephron loss, macrophage infiltration, and kidney fibrosis | 51 | |||
Becn1 | Global | Increased TGF-β1 expression and collagen accumulation | 47 | |||
Becn1 | Tubules | Exacerbated collagen deposition and kidney fibrosis. | 44 | |||
Mitophagy | Kidney fibrosis/UUO or adenine diet | Pink1 or Prkn | Global | Increased kidney macrophage-derived mROS, tubulointerstitial fibrosis, and impaired kidney function | 30 | |
Mfn2 | Myeloid lineage | Impaired macrophage mitochondrial biogenesis, increased macrophage-derived fibrotic responses, kidney fibrosis, serum creatinine, and BUN | 34 | |||
Autophagy | DN/Akita mice | Atg7 | Proximal tubules | Increased tubular hypertrophy, macrophage infiltration, and kidney fibrosis | 52 | |
DN/high-fat diet | Atg5 | Podocytes | Loss of podocytes and massive albuminuria | 53 | ||
DN/high glucose | Atg5 | Podocytes | Podocyte apoptosis, leaky GFB, and glomerulosclerosis | 17 | ||
DN/STZ | Atg5 | Endothelial cells | Capillary rarefactions, loss of fenestrations, and glomerular endothelial lesions | 17 | ||
Autophagy | Podocytopathies/PAN, adriamycin | Atg5 | Podocytes | Increased accumulation of oxidized proteins linked to proteinuria, loss of podocytes, and glomerulosclerosis | 13 | |
Podocytopathies/ unilateral nephrectomy | Atg7 | Podocytes | ER stress, cytoskeletal destabilization, foot process effacement, and albuminuria | 54 |
AKI, acute kidney injury; atg, autophagy-related; Becn1, beclin 1; BUN, blood urea nitrogen; CKD, chronic kidney disease; CLP, cecal ligation and puncture; DN, diabetic nephropathy; DRP1, dynamin-related protein 1; ER stress, endoplasmic reticulum-derived stress; FGF2, fibroblast growth factor 2; GFB, glomerular filtration barrier; IRI, ischemia-reperfusion injury; LPS, lipopolysaccharides; Map1lc3a, microtubule-associated protein 1 light chain 3α (LC3A); mROS, mitochondria-derived reactive oxygen species; PAN, puromycin aminonucleoside; Pink1, phosphatase and tensin homolog-induced kinase 1; Prkn, Parkin; STZ, streptozotocin; TGF-β1, transforming growth factor-β1; UUO, unilateral ureteral obstruction.